EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Empty Follicle Syndrome: Current Therapeutic Approaches and the Role of Triggering Agents in Assisted Reproductive Technology

Sofoklis Stavros, Athanasios Zikopoulos iD, Stefanos Dafopoulos, Nektaria Zagorianakou iD, Efthalia Moustakli iD, Anastasios Potiris iD, Ismini Anagnostaki, Theodoros Karampitsakos iD, Konstantinos Dafopoulos iD, Peter Drakakis

Medical Sciences · 02.07.2026 · 14 (3) · 369

DOI: 10.3390/medsci14030369 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 02.07.2026. Verfasst von Sofoklis Stavros und 9 weiteren Autor:innen. Beteiligte Einrichtung: Third Department of Obstetrics and Gynecology, University General Hospital "ATTIKON", Medical School, National and Kapodistrian University of Athens,…. Hauptthemen laut MEDLINE: Reproductive Techniques, Assisted, Ovulation Induction, Ovarian Follicle. Die Arbeit nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hallmark feature of empty follicle syndrome (EFS) is failure to retrieve oocytes from apparently mature follicles despite adequate ovarian stimulation and appropriate ovulation triggering. Although considered uncommon, with a reported prevalence ranging from 0.2% to 7%, EFS may have a profound clinical and psychological impact and can recur in assisted reproductive technology (ART) cycles. Modern classification systems divide EFS into genuine and false forms. Genuine EFS is potentially associated with intrinsic abnormalities involving luteinizing hormone/choriogonadotropin receptor (LHCGR) signaling, oocyte competence, and cumulus–oocyte interaction, whereas false EFS is primarily attributed to pharmacokinetic or pharmacodynamic factors resulting in inadequate trigger exposure. Borderline EFS represents a third phenotype characterized by incomplete or partial impairment of final oocyte maturation. This review examines the pharmacodynamics of ovulation-triggering agents, including human chorionic gonadotropin (hCG), gonadotropin-releasing hormone (GnRH) agonist protocols, and dual-trigger strategies, and their roles in regulating final oocyte maturation. The molecular aspects of periovulatory signal transduction and the mechanisms of LHCGR activation, epidermal growth factor (EGF)-like pathways, and meiotic resumption in relation to EFS etiopathogenesis will be described. The impact of patient-dependent conditions like obesity, poor ovarian reserve, polycystic ovary syndrome (PCOS), and pituitary response on trigger response will be assessed. New approaches like post-trigger monitoring of hormones and rescue treatment with gonadotropins represent a valuable method for avoiding cycle cancellation in patients at risk. Overall, EFS is increasingly regarded not as a single disorder but as a heterogeneous spectrum of periovulatory dysfunction arising from pharmacological, endocrine, and intrinsic ovarian factors that impair completion of final oocyte maturation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reproductive Techniques, AssistedOvulation InductionOvarian FollicleHumansFemaleChorionic GonadotropinOocytesGonadotropin-Releasing HormoneSignal TransductionReceptors, LH

Stichwörter der Autor:innen

GnRH agonistLHCGRcumulus–oocyte complexdual stimulation protocolfinal oocyte maturationhCG pharmacokineticsoocyte retrieval failureovarian stimulation protocolsperiovulatory signaling cascade

Substanzen

Chorionic GonadotropinGonadotropin-Releasing HormoneReceptors, LH

Autor:innen und Institutionen

  • Third Department of Obstetrics and Gynecology, University General Hospital "ATTIKON", Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
  • Department of Reproductive Medicine and Surgery, University College London Hospitals NHS Foundation Trust, 235 Euston Road, London NW1 2BU, UK.
  • University General Hospital of Patras, 26504 Rio, Greece.
  • Department of Nursing, School of Health Sciences, University of Ioannina, 4th Kilometer National Highway Str. Ioannina-Athens, 45500 Ioannina, Greece.
  • Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.
  • Department of Obstetrics and Gynaecology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41110 Larissa, Greece.

ORCID-Profile: Athanasios Zikopoulos, Nektaria Zagorianakou, Efthalia Moustakli, Anastasios Potiris, Theodoros Karampitsakos, Konstantinos Dafopoulos

Zitieren

APA

Stavros, S., Zikopoulos, A., Dafopoulos, S., Zagorianakou, N., Moustakli, E., Potiris, A., Anagnostaki, I., Karampitsakos, T., Dafopoulos, K., & Drakakis, P. (2026). Empty Follicle Syndrome: Current Therapeutic Approaches and the Role of Triggering Agents in Assisted Reproductive Technology. Medical Sciences, 14(3), 369. https://doi.org/10.3390/medsci14030369

Vancouver

Stavros S, Zikopoulos A, Dafopoulos S, Zagorianakou N, Moustakli E, Potiris A, et al. Empty Follicle Syndrome: Current Therapeutic Approaches and the Role of Triggering Agents in Assisted Reproductive Technology. Medical Sciences. 2026;14(3):369. doi:10.3390/medsci14030369

BibTeX
@article{Stavros2026,
  author = {Stavros, Sofoklis and Zikopoulos, Athanasios and Dafopoulos, Stefanos and Zagorianakou, Nektaria and Moustakli, Efthalia and Potiris, Anastasios and Anagnostaki, Ismini and Karampitsakos, Theodoros and Dafopoulos, Konstantinos and Drakakis, Peter},
  title = {Empty Follicle Syndrome: Current Therapeutic Approaches and the Role of Triggering Agents in Assisted Reproductive Technology},
  journal = {Medical Sciences},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {369},
  doi = {10.3390/medsci14030369}
}
Kostenlos starten →